California And Berlin

CARLSBAD, California and BERLIN, May 17, 2011 - Life Technologies Corporation (www.lifetech.com/) (NASDAQ: LIFE) and ProBioGen AG (www.probiogen.de/) today announced the availability of Gibco(R) Freedom(TM) Cell Line Development Kits (www.invitrogen.com/freedom.html), a new line of royalty-free products that integrate cells, reagents, culture media and protocols to bring simplicity and flexibility, eliminating up to two months in the earliest stages of new biological drug development.